Hanall Biopharma Co.,Ltd
KRX:009420.KS
35,850 (KRW) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Hanall Biopharma Co.,Ltd |
Symbool | 009420.KS |
Munteenheid | KRW |
Prijs | 36,000 |
Beurswaarde | 1,825,511,832,000 |
Dividendpercentage | 0% |
52-weken bereik | 24,650 - 46,750 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Sean Jeong |
Website | https://www.hanall.co.kr |
An error occurred while fetching data.
Over Hanall Biopharma Co.,Ltd
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)